Skip to content

Dance Workshop on Balance of Hemiparetic Patients

Effects of a Dance Workshop on the Balance Abilities of Hemiparetic Patients

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03149458
Acronym
DanceStudio
Enrollment
40
Registered
2017-05-11
Start date
2017-03-15
Completion date
2021-01-01
Last updated
2019-07-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hemiparesis

Keywords

stroke, balance, dance

Brief summary

The majority of hemiparetic patients have balance disorders, which impact independence in daily living activities and walking. Conventional techniques used in rehabilitation improve balance but have shown no effects on dynamic balance required during walking. Recently dance is proposed to improve dynamic balance in older people and people with Parkinson's disease. Although many studies showed that dance is an effective activity to improve balance in these people, it has never been assessed in hemiparetic patients (except a case report). The aim of this study is to show that a dance program improves the balance of hemiparetic patients, compared to a control group. This randomized controlled study aims to include 40 hemiparetic patients who will perform a dance program (experimental group) or a upper-limb rehabilitation program (control group) for 8 one-hour sessions.

Detailed description

Randomized controlled study aims to include 40 hemiparetic patients who will perform a dance program (experimental group) or a upper-limb rehabilitation program (control group) for 8 one-hour sessions. These activities are carried out in the form of a workshop and are already proposed in common practice in the service. They are carried out by the physiotherapists of the service. Patients are assigned in one of two study groups. It is specified that they will be able to carry out the program of the opposing group at the end of the study in order to limit the disappointment effect. The evaluations will be carried out at 4 and 8 weeks and will mainly rely on data of balance, function, quality of life and satisfaction

Interventions

OTHERdance

dance program

OTHERcontrol

upper limb rehabilitation

Sponsors

Fondation Garches
CollaboratorOTHER
Centre d'Investigation Clinique et Technologique 805
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

randomized controlled study

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patient who signed the consent letter * Male or female adults age ≥ 18 years, * Hemiparetic patient * Patient with balance disorders, able to walk alone and perform a U-turn, with or without technical assistance.

Exclusion criteria

* Bilateral brain lesions, cerebellar syndrome * Other pathology or impairment that may interfere with the study such as visual, cardiovascular or other uncontrolled medical conditions * Patient who underwent surgery of the musculoskeletal system in The 6 months prior to inclusion * Major cognitive disorders not allowing the dance activity or the passing of evaluations * Behavioral disorders not allowing group workshops * Pregnant woman, breastfeeding * Non-affiliation to a social security scheme (beneficiary or beneficiary)

Design outcomes

Primary

MeasureTime frameDescription
Timed up and Go5minget up, walk 3m, turn around and return sit down

Secondary

MeasureTime frameDescription
Berg Balance Scale10minclinical scale assessing balance. 14-item scale designed to measure balance of the older adult in a clinical setting. Scoring: A five-point scale, ranging from 0-4. 0 indicates the lowest level of function and 4 the highest level of function. Total Score = 56

Countries

France

Contacts

Primary ContactFrançois GENET, PhD
francois.genet@aphp.fr+33 (1) 47 10 70 68
Backup ContactFatima IZEDAREN
fatima.izedaren@aphp.fr+33 (1)47 10 44 49

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026